News from mimedx, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Sep 08, 2014, 16:49 ET

MiMedx To Webcast Its Analyst Day On October 14th

 MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer  of  patent  protected...

Sep 03, 2014, 09:34 ET

Fifth MiMedx Scientific Study Published In Peer-Reviewed Journal

 MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and...

Aug 04, 2014, 13:33 ET

MiMedx To Present At 34th Annual Canaccord|Genuity Growth Conference

 MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and...

Jul 28, 2014, 23:00 ET

MiMedx Announces Record Second Quarter Results

 MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and...

Jul 23, 2014, 07:59 ET

MiMedx Files Its Initial Investigational New Drug Application

 MiMedx Group, Inc.  (NASDAQ: MDXG), an integrated developer, processor and marketer of patent-protected regenerative biomaterials and...

Jul 22, 2014, 16:51 ET

Restrospective Analysis Finds MiMedx EpiFix® As Most Effective In Rapid Resolution Of Diabetic Foot Ulcers When Compared With Two Other Skin Substitutes

 MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and...

Jul 15, 2014, 08:42 ET

MiMedx Announces Release Date For 2014 Second Quarter Results

MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and bioimplants...

Jul 14, 2014, 10:47 ET

MiMedx Announces Revised Local Coverage Determination From Medicare Contractor That Includes EpiFix®

MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and bioimplants...

Jun 19, 2014, 11:15 ET

MiMedx Expects To File Its First Investigational New Drug Application In July

 MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent-protected regenerative biomaterials and...

Jun 19, 2014, 10:45 ET

MiMedx Increases Guidance For Second Quarter And Full Year 2014

 MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent-protected regenerative biomaterials and...

Jun 04, 2014, 10:02 ET

MiMedx Board Applauds Dismissal Of Lawsuit Against Chairman & CEO

 The Board of Directors of MiMedx Group, Inc. (NASDAQ: MDXG), announced today that the Board applauds the dismissal of the lawsuit brought...

May 27, 2014, 17:15 ET

MiMedx Increases Lower End Of Guidance For Second Quarter And Full Year 2014

 MiMedx Group, Inc.  (NASDAQ: MDXG), an integrated developer, processor and marketer of patent-protected regenerative biomaterials and...

May 23, 2014, 09:02 ET

MiMedx to Present at the Jefferies 2014 Healthcare Conference

 MiMedx (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and bioimplants processed...

May 20, 2014, 13:48 ET

MiMedx Declines To Participate In NAD Review Proceeding

MiMedx Group, Inc.  (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and...

May 15, 2014, 08:28 ET

MiMedx To Present At The 11th Annual Craig-Hallum Institutional Investor Conference

 MiMedx (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and bioimplants...

May 12, 2014, 08:30 ET

MiMedx Announces $10 Million Stock Repurchase Program

 MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent-protected regenerative biomaterials and...

May 06, 2014, 16:44 ET

Two New MiMedx Scientific Studies Published In Peer-Reviewed Journals

 MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent-protected regenerative biomaterials and...

Apr 29, 2014, 16:41 ET

MiMedx Issued Four New U.S. Patents For Placental Tissue Allografts

 MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent-protected regenerative biomaterials and...

Apr 25, 2014, 07:30 ET

MiMedx Announces Record Quarterly Results

 MiMedx Group, Inc.  (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials...

Apr 23, 2014, 11:12 ET

MiMedx at SAWC Spring 2014: Multiple Studies And Clinical Experience Demonstrate Clinical And Cost Effectiveness Of EpiFix Allograft For Treatment Of Hard-to-Heal Wounds

EpiFix®, dehydrated human amnion/chorion membrane (dHACM) allografts, were shown to be clinically and cost effective in the treatment of...